Compare CF Industries Holdings, Inc. (CF) vs HCA Health Inc (HCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CF Industries Holdings, Inc. vs HCA Health Inc — how do they compare? CF Industries Holdings, Inc. trades at $117.56 (market cap $17.83B), while HCA Health Inc trades at $411.87 (market cap $89.08B). The key difference: HCA Health Inc is far larger — about 5× CF Industries Holdings, Inc.'s market cap, and CF Industries Holdings, Inc. pays the higher dividend (2.04%). Which is the better fit depends on your goals.
| CF | HCA | |
|---|---|---|
Market Cap | $17.83B | $89.08B |
Sector | Basic Materials | Health |
52-Week High | $137.55 | $545.13 |
52-Week Low | $76.08 | $361.32 |
Enterprise Value | $18.96B | $139.62B |
Dividend Yield | 2.04% | 0.76% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CF Industries Holdings (CF) trades at $117.57, down 3.25% today, with a bearish technical signal. The stock shows strong profitability with a 27.12% net margin and a low P/E of 8.74, indicating potential undervaluation. Recent Q2 2026 earnings missed estimates but revenue grew 17.6% year-over-year, supported by strong nitrogen pricing. The company maintains solid cash flow, with net cash flow turning positive to $368 million in 2025 after two years of negatives.
The outlook is mixed; robust fundamentals and a consensus price target of $119.60 suggest upside, but near-term headwinds include volatile fertilizer demand and execution risks from operational issues like the Yazoo City outage. Long-term growth is supported by tight global nitrogen supply conditions into 2027.
HCA Healthcare trades at $414.03, up 0.16% today, with strong technical momentum as price sits above key support levels. The company demonstrates solid fundamentals with Q2 2026 earnings beating estimates, revenue growth to $75.6B in 2025, and consistent dividend payments. Recent management appointments signal strategic focus on clinical operations and ambulatory services.
HCA presents a compelling investment case with attractive valuation (P/E 13.8), analyst consensus price target of $449.93 (8.7% upside), and strong institutional support. However, risks include ongoing legal investigations, rising expenses impacting margins, and high debt levels at 80.9% debt-to-asset ratio that could constrain financial flexibility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About CF Industries Holdings, Inc.
CF Industries is a leading producer and distributor of nitrogen fertilizers. The company operates seven nitrogen facilities in North America and holds joint venture interests in further production capacity in the United Kingdom and Trinidad and Tobago. CF makes nitrogen primarily using low-cost U.S. natural gas as its feedstock, making CF one of the lowest-cost nitrogen producers globally.
Read more on CF →About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →
